This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Medical devices like group’s surgical robots have already been hit by the new US...
Latest executive order could shake up US pharma industry
Latest executive order could shake up US pharma industry
Medical devices like J&J’s surgical robots have already been hit by the new US c...
US pharmaceutical group says patient in study ‘experienced potential drug-induce...
Move comes as government seeks to boost UK’s standing as drugs research leader
Fears that pharmaceuticals could yet be hit by tariffs have sent shares sharply ...
Pharma group builds out American supply chains as part of preparations for poten...
Under the scheme, drugmakers discount the price of medicines sold in bulk to the...
US consumers are likely to be hit by the price rises across sectors from aviatio...
US consumers are set to be the biggest victims with cost increases set to be pas...
Deal is latest sign of the uptick in exits by private equity groups despite slug...
Acquisitions hold the cure for pharma companies’ chronic patent cliff problem
AI unit is boosted by first external funding round led by OpenAI-backer Thrive C...
Peter Marks says ‘truth and transparency are not desired’ by health secretary as...
European Medicines Agency says risks of potentially fatal side effects from dona...
US hedge fund gauged investor interest in German conglomerate’s consumer health ...
Once researchers begin wondering whether their government might pull the rug fro...
The biotech group created a revolutionary technology but it never hit on a susta...
The health benefits could be so extreme that it upends the annuity market, hitti...
London-listed drugmaker will establish research centre in Beijing
Ozempic might feature in future US negotiations with Denmark over Greenland
DNA sequencing specialist’s decision to list in London in 2021 was seen as a vic...
Experts say there are regional disparities in medication access even as prescrip...